Article
Dendritic cells break tolerance and induce protective immunity against a melanocyte differentiation antigen in an autologous melanoma model.
Cancer research - 15 Dec 2000
Schreurs M W, Eggert A A, de Boer A J, Vissers J L, van Hall T, Offringa R, Figdor C G, Adema G J
Abstract excerpt
Tyrosinase-related protein (TRP) 2 belongs to the melanocyte differentiation antigens and has been implicated as a target for immunotherapy of human as well as murine melanoma. In the current report, we explored the efficacy of nonmutated epitopes with differential binding affinity for MHC class I, derived from mouse TRP2 to induce CTL-mediated, tumor-reactive immunity in vivo within the established B16 melanoma...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
